Cytochrome P450 3A Inhibitor
16 drugs across 10 manufacturers|7 Generic,9 Brand
The Cytochrome P450 3A Inhibitor class contains 16 NDCs from 10 manufacturers (7 generic, 9 brand), at an average NADAC of $38.70 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
16
7G / 9B
Manufacturers
10
Avg $38.6970/unit
Avg 7d Change
-0.47%
Across 10 drugs with changes
7d Activity
of 16 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
10 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
Frequently Asked Questions
How many drugs are in the Cytochrome P450 3A Inhibitor class?
The Cytochrome P450 3A Inhibitor class contains 16 NDCs from 10 manufacturers — 7 generic and 9 brand products.
What is the average price of Cytochrome P450 3A Inhibitor drugs?
The average NADAC for the Cytochrome P450 3A Inhibitor class is $38.6970 per unit across 16 NDCs.
Is generic cheaper than brand in the Cytochrome P450 3A Inhibitor class?
Among products priced per EA, the average generic NADAC in this class is $1.8702, versus $75.3678 for brand — brand products average about 40× the generic price.
Which manufacturers make Cytochrome P450 3A Inhibitor drugs?
10 manufacturers make drugs in the Cytochrome P450 3A Inhibitor class. Ranked by number of NDCs, the largest are AbbVie Inc. (4), Janssen Products LP (2), Gilead Sciences, Inc. (2), Camber Pharmaceuticals Inc. (2), E.R. Squibb & Sons, L.L.C. (1).
How has Cytochrome P450 3A Inhibitor pricing changed recently?
Over the past 7 days, 4 NDCs in this class rose and 6 fell, with a class-wide average change of -0.5%.